18.9%); a favorable trend was also observed in patients with non‐AC histology and wild‐type EGFR .
← all excerpts
Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab.
1
—
—